Indocyanine Green Labeling of Tumors in the Liver Recurring After Radiofrequency Ablation Enables Complete Resection by Fluorescence-guided Surgery-Reference-Cited by-同舟云学术

Indocyanine Green Labeling of Tumors in the Liver Recurring After Radiofrequency Ablation Enables Complete Resection by Fluorescence-guided Surgery

Published:2022-02-26 Issue:3 Volume:42 Page:1345-1350
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

TASHIRO YOSHIHIKO,AOKI TAKESHI,HIRAI TAKAHITO,KOIZUMI TOMOTAKE,KUSANO TOMOKAZU,MATSUDA KAZUHIRO,YAMADA KOSUKE,NOGAKI KOJI,HAKOZAKI TOMOKI,WADA YUSUKE,SHIBATA HIDEKI,TOMIOKA KODAI,YAMAZAKI TATSUYA,SAITO KAZUHIKO,FUJIMORI AKIRA,ENAMI YUTA,HOFFMAN ROBERT M.

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laparoscopic Anatomical Liver Resection Using Liver Mapping of Incidental Indocyanine Green Fluorescence due to Cholestasis;Anticancer Research;2023-11-29

2. Indocyanine Green Fluorescence Imaging in the Surgical Management of Skin Squamous Cell Carcinoma;Clinical, Cosmetic and Investigational Dermatology;2023-11

3. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study;Journal of Personalized Medicine;2023-05-20

4. Real-time administration of indocyanine green in combination with computer vision and artificial intelligence for the identification and delineation of colorectal liver metastases;Surgery Open Science;2023-03

5. Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications;The American Journal of Surgery;2022-10